R&D
FCoV-19 VAC (COVID-19 Vaccine for cats and dogs)
Technology
Recombinant
protein-based
vaccine platform
- In a study conducted since March 2020, vaccine composition was selected. The vaccine contains RBD(Receptor Binding Domain) and
S1 subunit, which are the key to the infection of SARS-CoV-2 virus(causative agent of COVID-19). We used a high-purity antigen with the same
production and purification process as human medicines. - SARS-CoV-2 Spike 1(S1) recombinant protein
- SARS-CoV-2 Receptor binding domain(RBD) of S1 recombinant protein
- Adjuvant
